What is the recommended misoprostol (prostaglandin E1 analog) regimen for medical termination of pregnancy (MTP) at 17 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Misoprostol Regimen for MTP at 17 Weeks Gestation

For medical termination of pregnancy at 17 weeks gestation, administer misoprostol 400 mcg vaginally every 3-6 hours (up to 5 doses maximum), which is the optimal regimen for second-trimester abortion based on efficacy and safety profile.

Recommended Dosing Protocol

  • Vaginal misoprostol 400 mcg every 3-6 hours is the preferred regimen for second-trimester termination between 13-22 weeks gestation 1, 2
  • The maximum recommended number of doses is 5 doses within a 24-hour period to minimize side effects while maintaining efficacy 2
  • Vaginal administration is significantly more effective than oral administration, with a mean induction-to-delivery interval of 17.5 hours (vaginal) versus 33 hours (oral), and 93% delivery rate within 24 hours for vaginal route 3

Critical Considerations for Scarred Uterus

  • If the patient has a previous cesarean section or uterine scar, use lower doses and longer intervals (consider 200-400 mcg every 6 hours) and never double the dose if there is no initial response 1
  • Uterine rupture, though rare, is a serious complication that increases with higher doses and scarred uteri 2

Optimal Regimen with Mifepristone (When Available)

  • The combination of mifepristone followed by misoprostol has the highest efficacy and shortest abortion interval for second-trimester termination 1, 2
  • If mifepristone is available, administer it 24-48 hours before starting misoprostol to improve outcomes 2

Expected Efficacy and Timing

  • Success rates with misoprostol alone at this gestational age range from 91.8% to over 90% 4
  • Mean expulsion time is approximately 9-10 hours, with most women delivering within 24 hours 4, 3

Common Side Effects to Anticipate

  • Abdominal pain/cramping occurs in approximately 80% of cases 4
  • Shivering (17%), nausea/vomiting (10%), fever and chills are common 2, 4
  • Gastrointestinal effects including diarrhea occur in 4-10% of cases, and are more likely with doses exceeding 800 mcg 1, 4

Management of Incomplete Abortion

  • Placental retention occurs in approximately 8-9% of cases 4
  • Have surgical backup available for incomplete abortion, ongoing pregnancy, or medical complications requiring intervention 5

Important Caveats

  • Do not exceed 800 mcg total dose per administration cycle as higher doses significantly increase side effects, particularly diarrhea, without improving efficacy 1
  • For gestational ages beyond 22 weeks, reduce both dose and frequency of administration due to increased uterine sensitivity 2
  • Counsel patients about teratogenic risks if abortion fails, as misoprostol exposure is associated with congenital anomalies 1

References

Research

The use of misoprostol in termination of second-trimester pregnancy.

Taiwanese journal of obstetrics & gynecology, 2011

Research

Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007

Research

Use of misoprostol for the termination of second trimester pregnancies.

Archives of gynecology and obstetrics, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.